Newsroom

Filtrer par

COVID-19, how we adapt and respond to the situation.


Learn More

New publication of a large French clinical trial evaluating Ostenil Plus in osteoarthritis

Learn More
TRB Chemedica International S.A. and InnoMedica Holding AG enter in a long-term relationship regarding the production of GM1 (monosialotetrahexosylganglioside) and its development as a liposomal formulation under the trade name Talineuren®

TRB Chemedica announces a collaboration with InnoMedica to develop liposomal GM1

Learn More

TRB Pharma Brazil awarded the Cândido Fontoura Necklace of Pharmaceutical Industry Merit

Learn More
Mein-Auge-mobile-App-TRB-Chemedica

The MEIN AUGE reminder mobile application for your eye drops is now available

Learn More